The future of periodontal disease diagnosis using salivary diagnostics appears promising due to its potential to revolutionize how dental health is assessed. Salivary diagnostics offer significant benefits, notably the ability to detect very low levels of specific biomarkers associated with periodontal disease. This sensitivity allows for early detection and intervention, which is crucial for preventing disease progression. Moreover, the non-invasive nature of salivary tests makes them highly attractive for both patients and healthcare providers. However, challenges such as standardization of testing protocols, variability in saliva composition, and integration into existing diagnostic workflows need to be addressed to ensure reliable and consistent results in clinical practice. The development and implementation of modern technologies that use specific biomarkers at the chair side appear to be on the horizon and are likely to increase clinical diagnostic and prognostic insight.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.